Table 1.
Patient characteristics at baseline and at follow‐up.
| Parameters | Control, n = 67 | VNS, n = 43 | Pooled, n = 110 |
|---|---|---|---|
| Gender | 29♀/38♂ | 24♀/19♂ | 53♀/57♂ |
| Height (m) | 1.69 ± 0.01, n = 67 | 1.68 ± 0.02, n = 43 | 1.69 ± 0.01, n = 110 |
| Follow‐Up (years) | 6.1 ± 0.4, n = 16 | 7.9 ± 0.7, n = 20 | 7.1 ± 0.5, n = 36 |
| Duration of VNS (years) | N/A | 4.5 ± 0.5, n = 24 | N/A |
| Baseline | |||
| Age (years) | 34.7 ± 1.8, n = 67 | 39.6 ± 2.1, n = 39 | 36.5 ± 1.4, n = 106 |
| Body Weight (kg) | 81.0 ± 3.1, n = 43 | 79.3 ± 5.4, n = 18 | 80.5 ± 2.7, n = 61 |
| BMI (kg/m2) | 28.0 ± 1.1, n = 43 | 28.6 ± 1.7, n = 18 | 28.2 ± 0.9, n = 61 |
| Glucose (mg/dL) | 97.6 ± 2.4, n = 67 | 97.3 ± 3.3, n = 39 | 97.5 ± 1.9, n = 106 |
| Follow‐Up | |||
| Age (years) | 38.4 ± 3.6, n = 16 | 44.6 ± 2.7, n = 24 | 42.1 ± 2.2, n = 40 |
| Body Weight (kg) | 82.4 ± 9.1, n = 10 | 81.4 ± 3.8, n = 20 | 81.7 ± 3.9, n = 30 |
| Δ Body Weight (kg) | ‐1.1 ± 6.8, n = 5 | ‐4.5 ± 6.2, n = 5 | ‐2.8 ± 4.4, n = 10 |
| BMI (kg/m2) | 29.9 ± 2.6, n = 10 | 28.4 ± 1.4, n = 20 | 28.9 ± 1.3, n = 30 |
| Δ BMI (kg/m2) | ‐0.6 ± 2.5, n = 5 | ‐1.4 ± 2.1, n = 5 | ‐1.0 ± 1.5, n = 10 |
| Glucose (mg/dL) | 98.3 ± 4.2, n = 16 | 99.0 ± 3.4, n = 24 | 98.7 ± 2.6, n = 40 |
| Δ Glucose (mg/dL) | +5.2 ± 5.4, n = 16 | +5.2 ± 5.5, n = 20 | +5.2 ± 3.8, n = 36 |
Data were extracted from clinical files of 110 epilepsy patients. However, not all data were available from all patients, resulting in missing values. Thus, the number of subjects are provided for all parameters. BMI, body mass index; Δ, change from baseline to follow‐up. At both time points (baseline and follow‐up), there were no statistically significant differences between groups in any parameters.